POST Online Media Lite Edition


AMRI announces leadership team in Europe, North America

Staff writer |
Albany, N.Y., USA - Albany Molecular Research (AMRI) announced several promotions of key members of its leadership team.

Dr. Mark Sawicki has been promoted to vice president of business development for Europe.

As part of the company’s continuing strategy to increase European market share, Dr. Sawicki will drive the expansion and focus of AMRI’s European sales division by leading all sales activities to promote AMRI’s full spectrum of global scientific services, including drug discovery, development/small scale manufacturing, and large scale manufacturing.

Previously, Dr. Sawicki was responsible for sales activities for AMRI discovery services in North America and Europe as senior director of business development.

Dr. Sawicki joined AMRI in 2004 as director of business development.

Christopher Conway has been promoted to senior director of business development for North American Discovery Services.

Prior to joining AMRI, Mr. Conway held sales positions of increasing responsibility at Johnson & Johnson, culminating in the role of district manager for Johnson & Johnson’s Ortho-McNeil Neurologics Division.

Mr. Conway joined AMRI in 2008 as manager of business development.

Angie Urdanoff has been promoted to senior director, sales operations and will have increased oversight for driving the company’s global sales operations efforts.

Before joining AMRI, Ms. Urdanoff worked for Pitney Bowes Business Insight as managing director of Americas sales operations.

Prior to that, Ms. Urdanoff served as product and manufacturing manager for GE Silicones.

She was awarded GE’s Six Sigma Black Belt certification in 1996.


What to read next

AMRI hires chief information officer
AMRI announces CFO transition
AMRI promotes Steven R. Hagen to SVP, pharmaceutical development and manufacturing